|
[1]
|
Lareau, S.C., Fahy, B., Meek, P., et al. (2019) Chronic Obstructive Pulmonary Disease (COPD). American Journal of Respiratory and Critical Care Medicine, 199, 1-2.
|
|
[2]
|
李薇, 杨汀, 王辰. 中国慢性阻塞性肺疾病防治现状及进展[J]. 中国研究型医院, 2020, 7(5): 1-5.
|
|
[3]
|
Segal, L.N. and Martinez, F.J. (2018) Chronic Obstructive Pulmonary Disease Subpopulations and Phenotyping. Journal of Allergy and Clinical Immunology, 141, 1961-1971. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Riley, C.M. and Sciurba, F.C. (2019) Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review. JAMA, 321, 786-797.
|
|
[5]
|
Mukhopadhyay, H., Bairagi, A., Mukherjee, A., Prasad, A.K., Roy, A.D. and Nayak, A. (2025) Multidrug Resistant Acinetobacter Baumannii: A Study on Its Pathogenesis and Therapeutics. Current Research in Microbial Sciences, 8, Article 100331. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
习静, 脱鸣富, 魏育芳, 等. 不同病程COPD并发下呼吸道感染病原菌分离及耐药情况分析[J]. 中国抗生素杂志, 2020, 45(8): 798-803.
|
|
[7]
|
Li, Y., Wang, Z., Tan, L., Liang, L., Liu, S., Huang, J., et al. (2024) Hospitalization, Case Fatality, Comorbidities, and Isolated Pathogens of Adult Inpatients with Pneumonia from 2013 to 2022: A Real-World Study in Guangzhou, China. BMC Infectious Diseases, 24, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
郑少茂. ICU机械通气患者感染多重耐药鲍曼不动杆菌危险因素分析及其预测模型建立[D]: [硕士学位论文]. 海口: 海南医学院, 2021.
|
|
[9]
|
Nseir, S., Di Pompeo, C., Cavestri, B., et al. (2006) Multiple-Drug-Resistant Bacteria in Patients with Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence, Risk Factors, and Outcome. Critical Care Medicine, 34, 2959-2966.
|
|
[10]
|
陈晨, 杨德湘, 吴昊, 等. ICU机械通气患者感染鲍曼不动杆菌临床特征及预后分析[J]. 临床肺科杂志, 2022, 27(6): 862-866.
|
|
[11]
|
石江龙, 程娜, 向天新, 等. 耐碳青霉烯类鲍曼不动杆菌血流感染的危险因素及预后的评估指标[J]. 中国感染控制杂志, 2021, 20(12): 1082-1087.
|
|
[12]
|
Thorne, A., Luo, T., Durairajan, N.K., Kaye, K.S. and Foxman, B. (2019) Risk Factors for Endemic Acinetobacter Baumannii Colonization: A Case-Case Study. American Journal of Infection Control, 47, 1294-1297. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Shi, J., Mao, X., Cheng, J., Shao, L., Shan, X. and Zhu, Y. (2024) Risk Factors and Predictive Model for Nosocomial Infections by Extensively Drug-Resistant Acinetobacter Baumannii. Frontiers in Cellular and Infection Microbiology, 14, Article ID: 1475428. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Coloma Bazán, E. (2022) Urgent Hospitalization of Patients with Chronic Obstructive Pulmonary Disease: The Current Situation. Emergencias, 34, 83-84.
|
|
[15]
|
Ferrera, M.C., Labaki, W.W. and Han, M.K. (2021) Advances in Chronic Obstructive Pulmonary Disease. Annual Review of Medicine, 72, 119-134. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Subedi, S., Guntipally, M., Suwal, N., Thapa, R., Bashyal, S., Panth, N., et al. (2025) Cellular Senescence in Chronic Obstructive Pulmonary Disease: Molecular Mechanisms and Therapeutic Interventions. Ageing Research Reviews, 110, Article 102813. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Yu, X., Xiao, H., Liu, Y., Dong, Z., Meng, X. and Wang, F. (2025) The Lung-Brain Axis in Chronic Obstructive Pulmonary Disease-Associated Neurocognitive Dysfunction: Mechanistic Insights and Potential Therapeutic Options. International Journal of Biological Sciences, 21, 3461-3477. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Yu, S., Li, S., Zhang, J. and Fang, Q. (2024) Glucocorticoid Use in Patients Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations. International Journal of Chronic Obstructive Pulmonary Disease, 19, 431-438. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Xie, C., Yalikun, M., Ruan, Z., Yu, H., Huang, X., Zhu, H., et al. (2025) Macrophage Immunometabolism in Pulmonary Homeostasis and Chronic Lung Diseases. International Journal of Biological Sciences, 21, 6580-6598. [Google Scholar] [CrossRef]
|
|
[20]
|
Guo, J., Chen, Y., Zhang, W., Tong, S. and Dong, J. (2020) Moderate and Severe Exacerbations Have a Significant Impact on Health-Related Quality of Life, Utility, and Lung Function in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis. International Journal of Surgery, 78, 28-35. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Leuppi, J.D., Schuetz, P., Bingisser, R., Bodmer, M., Briel, M., Drescher, T., et al. (2013) Short-Term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: The Reduce Randomized Clinical Trial. JAMA, 309, 2223-2231. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Lipson, D.A., Crim, C., Criner, G.J., Day, N.C., Dransfield, M.T., Halpin, D.M.G., et al. (2020) Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 201, 1508-1516. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
黄伟, 袁华. 重症监护室内老年患者鲍曼不动杆菌血流感染的危险因素及预后[J]. 中国老年学杂志, 2020, 40(10): 2138-2141.
|
|
[24]
|
Gentry, S. and Gentry, B. (2017) Chronic Obstructive Pulmonary Disease: Diagnosis and Management. American Family Physician, 95, 433-441.
|
|
[25]
|
Peleg, A.Y., Seifert, H. and Paterson, D.L. (2008) Acinetobacter baumannii: Emergence of a Successful Pathogen. Clinical Microbiology Reviews, 21, 538-582. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Karageorgopoulos, D.E. and Falagas, M.E. (2008) Current Control and Treatment of Multidrug-Resistant Acinetobacter Baumannii Infections. The Lancet Infectious Diseases, 8, 751-762. [Google Scholar] [CrossRef] [PubMed]
|